271 related articles for article (PubMed ID: 33288545)
21. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
23. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A
Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516
[TBL] [Abstract][Full Text] [Related]
24. SLAMF7 and TREM1 Mediate Immunogenic Cell Death in Colorectal Cancer Cells: Focus on Microsatellite Stability.
Roh SA; Kwon YH; Lee JL; Kim SK; Kim JC
Anticancer Res; 2021 Nov; 41(11):5431-5444. PubMed ID: 34732412
[TBL] [Abstract][Full Text] [Related]
25. The novel immunoglobulin super family receptor SLAMF9 identified in TAM of murine and human melanoma influences pro-inflammatory cytokine secretion and migration.
Dollt C; Michel J; Kloss L; Melchers S; Schledzewski K; Becker K; Sauer A; Krewer A; Koll F; Schmieder A
Cell Death Dis; 2018 Sep; 9(10):939. PubMed ID: 30232321
[TBL] [Abstract][Full Text] [Related]
26. Increased SLAMF7
Liu J; Peng H; Yu T; Huang Y; Tan N; Pang L; Wu Y; Wang L
Pancreatology; 2023 Nov; 23(7):767-776. PubMed ID: 37661465
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
28. IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells.
Inozume T; Hanada K; Wang QJ; Yang JC
J Immunother; 2009; 32(2):109-17. PubMed ID: 19238009
[TBL] [Abstract][Full Text] [Related]
29. Fundamentals to therapeutics: Epigenetic modulation of CD8
Blake MK; O'Connell P; Aldhamen YA
Front Cell Dev Biol; 2022; 10():1082195. PubMed ID: 36684449
[TBL] [Abstract][Full Text] [Related]
30. Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers.
Menard LC; Fischer P; Kakrecha B; Linsley PS; Wambre E; Liu MC; Rust BJ; Lee D; Penhallow B; Manjarrez Orduno N; Nadler SG
Front Immunol; 2018; 9():2728. PubMed ID: 30534127
[TBL] [Abstract][Full Text] [Related]
31. SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7
Gogishvili T; Danhof S; Prommersberger S; Rydzek J; Schreder M; Brede C; Einsele H; Hudecek M
Blood; 2017 Dec; 130(26):2838-2847. PubMed ID: 29089311
[TBL] [Abstract][Full Text] [Related]
32. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
[TBL] [Abstract][Full Text] [Related]
33. SLAMF7 Is a Critical Negative Regulator of IFN-α-Mediated CXCL10 Production in Chronic HIV Infection.
O'Connell P; Pepelyayeva Y; Blake MK; Hyslop S; Crawford RB; Rizzo MD; Pereira-Hicks C; Godbehere S; Dale L; Gulick P; Kaminski NE; Amalfitano A; Aldhamen YA
J Immunol; 2019 Jan; 202(1):228-238. PubMed ID: 30530590
[TBL] [Abstract][Full Text] [Related]
34. SLAMF7 and IL-6R define distinct cytotoxic versus helper memory CD8
Loyal L; Warth S; Jürchott K; Mölder F; Nikolaou C; Babel N; Nienen M; Durlanik S; Stark R; Kruse B; Frentsch M; Sabat R; Wolk K; Thiel A
Nat Commun; 2020 Dec; 11(1):6357. PubMed ID: 33311473
[TBL] [Abstract][Full Text] [Related]
35. Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma.
Chakiryan NH; Kim Y; Berglund A; Chang A; Kimmel GJ; Hajiran A; Nguyen J; Moran-Segura C; Saeed-Vafa D; Katende EN; Lopez-Blanco N; Chahoud J; Rappold P; Spiess PE; Fournier M; Jeong D; Wang L; Teer JK; Dhillon J; Kuo F; Hakimi AA; Altrock PM; Mulé JJ; Manley BJ
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37185232
[TBL] [Abstract][Full Text] [Related]
36. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
37. Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
Chen YH; Chen SH; Hou J; Ke ZB; Wu YP; Lin TT; Wei Y; Xue XY; Zheng QS; Huang JB; Xu N
Aging (Albany NY); 2019 Oct; 11(21):9478-9491. PubMed ID: 31672930
[TBL] [Abstract][Full Text] [Related]
38. Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200.
Siva A; Xin H; Qin F; Oltean D; Bowdish KS; Kretz-Rommel A
Cancer Immunol Immunother; 2008 Jul; 57(7):987-96. PubMed ID: 18060403
[TBL] [Abstract][Full Text] [Related]
39. An Immune Atlas of Clear Cell Renal Cell Carcinoma.
Chevrier S; Levine JH; Zanotelli VRT; Silina K; Schulz D; Bacac M; Ries CH; Ailles L; Jewett MAS; Moch H; van den Broek M; Beisel C; Stadler MB; Gedye C; Reis B; Pe'er D; Bodenmiller B
Cell; 2017 May; 169(4):736-749.e18. PubMed ID: 28475899
[TBL] [Abstract][Full Text] [Related]
40. SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint.
Hajaj E; Eisenberg G; Klein S; Frankenburg S; Merims S; Ben David I; Eisenhaure T; Henrickson SE; Villani AC; Hacohen N; Abudi N; Abramovich R; Cohen JE; Peretz T; Veillette A; Lotem M
Elife; 2020 Mar; 9():. PubMed ID: 32122464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
